The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Bevacizumab     Injury: Neutrophil count decreased     Quarter: 2016Q3

Total Records: 84     Number of Pages: 5

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
127456451 Bevacizumab Neutrophil count decreased ROCHE 56.00 YR F 92 KG 20160915 US
127576561 Bevacizumab Neutrophil count decreased ROCHE 42.00 YR F 106 KG 20160919 US
127578011 Bevacizumab Neutrophil count decreased ROCHE 58.00 YR F 62 KG 20160919 US
127699001 Bevacizumab Neutrophil count decreased ROCHE 12.00 YR F 28 KG 20160922 CA
127794191 Bevacizumab Neutrophil count decreased ROCHE 77.00 YR F 65 KG 20160926 US
127800251 Bevacizumab Neutrophil count decreased ROCHE 66.00 YR F 97 KG 20160926 US
127819111 Bevacizumab Neutrophil count decreased ROCHE 60.00 YR F 101 KG 20160926 US
127820931 Bevacizumab Neutrophil count decreased ROCHE 51.00 YR F 102 KG 20160927 US
127821831 Bevacizumab Neutrophil count decreased ROCHE 75.00 YR F 64 KG 20160927 US
127825681 Bevacizumab Neutrophil count decreased ROCHE 76.00 YR F 58 KG 20160927 US
127825971 Bevacizumab Neutrophil count decreased ROCHE 0.00 F 116 KG 20160927 US
127826761 Bevacizumab Neutrophil count decreased ROCHE 55.00 YR F 128 KG 20160927 US
127828031 Bevacizumab Neutrophil count decreased ROCHE 73.00 YR F 57 KG 20160927 US
127829001 Bevacizumab Neutrophil count decreased ROCHE 60.00 YR F 59 KG 20160927 US
127831971 Bevacizumab Neutrophil count decreased ROCHE 61.00 YR F 92 KG 20160927 US
127832031 Bevacizumab Neutrophil count decreased ROCHE 52.00 YR F 53 KG 20160927 US
127832201 Bevacizumab Neutrophil count decreased ROCHE 66.00 YR F 95 KG 20160927 US
127872801 Bevacizumab Neutrophil count decreased ROCHE 67.00 YR F 89 KG 20160927 US
127873111 Bevacizumab Neutrophil count decreased ROCHE 63.00 YR F 99 KG 20160927 US
127873221 Bevacizumab Neutrophil count decreased ROCHE 67.00 YR F 0 20160927 US

Total Records: 84     Number of Pages: 5